Special Issue "Small Molecules as Antimicrobials"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 1 December 2020.
Interests: Medicinal chemistry; drug development; antimycobacterials; antibacterials
The World Health Organization (WHO) announced antimicrobial resistance (AMR) as a major threat to public health. The rapid development and spread of new resistance mechanisms has made many antimicrobials useless in treating clinically ill patients. Even medical procedures such as major surgery, organ transplantation, and cancer chemotherapy have become very risky in the absence of effective antimicrobials for prevention and treatment of infections. Therefore, there is an urgent need for new, better, and more effective antimicrobials.
We invite authors to submit original research and review articles related to up-to-date and ongoing research focusing on the development and evaluation of potential new antimicrobial agents, as well as on the investigation of improved delivery protocols of both existing and new antimicrobial agents. We aim to highlight research covering all stages of investigation, such as in silico studies, synthesis efforts, in vitro studies, and in vivo evaluations.
Potential topics include, but are not limited to:
- Development and testing of novel and effective antimicrobial agents;
- Antimicrobial agents active against drug-resistant forms;
- Recent advances in antimicrobial drug delivery.
Prof. Poce Giovanna
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- medicinal chemistry